"Frans is a seasoned leader with more than 30 years of diverse quality experience spanning large global companies and smaller healthcare firms, and cross-sector expertise including pharmaceuticals, biotechnology and medical devices," said Begley. "With his proven track record in working with regulatory bodies around the world and implementing robust global quality systems, Frans' appointment reinforces Hospira's commitment to establishing quality as a strategic, competitive advantage across our global operations. We are excited to have him lead the continued transformation of our patient-focused quality organization."
Under Dubois' leadership, Hospira will advance its global quality and compliance strategies, drive the continuous improvement of established quality procedures to ensure that processes and products meet high internal standards and regulatory requirements, and ultimately deliver high-quality, cost-effective products to customers.
Previously, Dubois, 57, served as vice president of quality for Tengion, Inc., where he was responsible for the biotechnology company's quality and compliance operations. Prior to joining Tengion, he spent more than 10 years at Johnson & Johnson in increasing roles of responsibility, most recently as vice president, Global External Manufacturing and Supplier Quality Operations. In this position, Dubois was responsible for driving transformation of the supply chain through quality operations at external sites, including pharmaceutical suppliers and bulk active pharmaceutical ingredient (API) and biologics manufacturing.
During his career, Dubois served in numerous quality and operations roles and has also worked as a business consultant to several pharmaceutical companies. He earned his master's degree in pharmacy from Leiden University, the Netherlands.
About Hospira
Hospira, Inc. is a global specialty pharmaceutical and medication delivery company dedicated to Advancing Wellness. As the world leader in specialty generic injectable pharmaceuticals, Hospira offers one of the broadest portfolios of generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management solutions. Through its products, Hospira helps improve the safety, cost and productivity of patient care. The company is headquartered in Lake Forest, Ill., and has approximately 13,500 employees. Learn more at www.hospira.com.
SOURCE Hospira, Inc.
